002880 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Shenzhen Weiguang Biological Products Co., Ltd. engages in the manufacturing, research and development of drug and blood products. Its products include human albumin, human immunoglobulin, human hepatitis B immunoglobulin, human rabies immunoglobulin, tetanus immunoglobulin and histamine human immunoglobulin. The company was founded on October 22, 2001 and is headquartered in Shenzhen, China.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
002880 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company